Faber began writing his bearish outlook reports in the 1970s, initially for personal use and to address the lack of awareness among Americans about foreign exchange rates, the dollar’s value against gold, and European currencies at the time. As the publisher of the widely respected “Gloom, Boom & Doom Report,” he offers contrarian perspectives on global financial markets, highlighting the importance of cautious investing and the potential for significant economic downturns.
Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downside
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a
November 5, 2024